Literature DB >> 5101786

Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency.

W C Mentzer, R L Baehner, H Schmidt-Schönbein, S H Robinson, D G Nathan.   

Abstract

Radioisotope studies of bilirubin turnover, ferrokinetics, and red cell survival ((51)Cr) in a patient with erythrocyte PK deficiency have provided evidence for prompt reticulocyte sequestration and destruction by the reticuloendothelial system. More mature erythrocytes appeared to survive well despite their deficiency of PK. PK-deficient reticulocytes, dependent upon oxidative phosphorylation for ATP production, are exquisitely sensitive to cyanide- or nitrogen-induced mitochondrial inhibition. If oxidative phosphorylation is unavailable, ATP levels decline rapidly, producing alterations in the cell membrane which allow massive losses of potassium and water. The result is a shrunken, spiculated, viscous cell whose rheologic properties would favor its sequestration by the reticuloendothelial system. Those reticulocytes with particularly low levels of PK exhibit very low glycolytic rates and thus are uniquely reliant upon oxidative phosphorylation. Other reticulocytes, better endowed with PK activity, can meet the increased ATP requirements of young erythrocytes. Upon reaching maturity, such cells have diminished ATP needs and can, therefore, survive despite their enzyme deficiency.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5101786      PMCID: PMC291977          DOI: 10.1172/JCI106539

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  EXTREME HEMOLYSIS AND RED-CELL DISTORTION IN ERYTHROCYTE PYRUVATE KINASE DEFICIENCY. II. MEASUREMENTS OF ERYTHROCYTE GLUCOSE CONSUMPTION, POTASSIUM FLUX AND ADENOSINE TRIPHOSPHATE STABILITY.

Authors:  D G NATHAN; F A OSKI; V W SIDEL; L K DIAMOND
Journal:  N Engl J Med       Date:  1965-01-21       Impact factor: 91.245

2.  Hereditary non-spherocytic hemolytic anemia of the pyruvate-kinase deficient type.

Authors:  H S BOWMAN; F PROCOPIO
Journal:  Ann Intern Med       Date:  1963-04       Impact factor: 25.391

3.  EXTREME HEMOLYSIS AND RED-CELL DISTORTION IN ERYTHROCYTE PYRUVATE KINASE DEFICIENCY. I. MORPHOLOGY, ERYTHROKINETICS AND FAMILY ENZYME STUDIES.

Authors:  F A OSKI; D G NATHAN; V W SIDEL; L K DIAMOND
Journal:  N Engl J Med       Date:  1964-05-14       Impact factor: 91.245

Review 4.  Hereditary hemolytic anemias associated with specific erythrocyte enzymopathies.

Authors:  W N Valentine
Journal:  Calif Med       Date:  1968-04

Review 5.  Rheology of blood.

Authors:  E W Errill
Journal:  Physiol Rev       Date:  1969-10       Impact factor: 37.312

6.  Life-span and organ sequestration of the red cells in pyruvate kinase deficiency.

Authors:  D G Nathan; F A Oski; D R Miller; F H Gardner
Journal:  N Engl J Med       Date:  1968-01-11       Impact factor: 91.245

7.  [Anomalies of glycolysis during hemolytic anemia due to deficiency of pyruvate kinase in the erythrocytes].

Authors:  P Cartier; A Najman; J P Leroux; H Temkine
Journal:  Clin Chim Acta       Date:  1968-10       Impact factor: 3.786

Review 8.  Pyruvate kinase deficiency and related disorders of red cell glycolysis.

Authors:  A S Keitt
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

9.  Influence of deformability of human red cells upon blood viscosity.

Authors:  H Schmid-Schönbein; R Wells; J Goldstone
Journal:  Circ Res       Date:  1969-08       Impact factor: 17.367

10.  A low Km phosphoenolpyruvate mutant in the Amish with red cell pyruvate kinase deficiency.

Authors:  F A Oski; H Bowman
Journal:  Br J Haematol       Date:  1969-09       Impact factor: 6.998

View more
  18 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  2006 Association of American Physicians George M. Kober Medal. Introduction of David G. Nathan, MD.

Authors:  Edward J Benz
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

3.  Diminished spectrin extraction from ATP-depleted human erythrocytes. Evidence relating spectrin to changes in erythrocyte shape and deformability.

Authors:  S E Lux; K M John; T E Ukena
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

4.  Compound heterozygosity in PKLR gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency.

Authors:  Shruti Bagla; Kanta Bhambhani; Manisha Gadgeel; Steven Buck; Jian-Ping Jin; Yaddanapudi Ravindranath
Journal:  Haematologica       Date:  2019-04-04       Impact factor: 9.941

5.  Function and dysfunction.

Authors:  Narla Mohandas
Journal:  Blood       Date:  2018-05-17       Impact factor: 22.113

6.  Erythrocytapheresis as a novel treatment option for adult patients with pyruvate kinase deficiency.

Authors:  Rawia F G Jensen; Morten H Dziegiel; Klaus Rieneck; Henrik Birgens; Andreas Glenthøj
Journal:  Haematologica       Date:  2020-04-09       Impact factor: 9.941

Review 7.  Blood rheology.

Authors:  J Stuart; M W Kenny
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

8.  Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications.

Authors:  Gholson J Lyon; Tao Jiang; Richard Van Wijk; Wei Wang; Paul Mark Bodily; Jinchuan Xing; Lifeng Tian; Reid J Robison; Mark Clement; Yang Lin; Peng Zhang; Ying Liu; Barry Moore; Joseph T Glessner; Josephine Elia; Fred Reimherr; Wouter W van Solinge; Mark Yandell; Hakon Hakonarson; Jun Wang; William Evan Johnson; Zhi Wei; Kai Wang
Journal:  Discov Med       Date:  2011-07       Impact factor: 2.970

9.  Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: clinical, genetic and molecular studies in six new Spanish patients.

Authors:  J L Vives-Corrons; J Marie; M A Pujades; A Kahn
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

10.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.